In recent years, it has been found that a variety of immune cells in patients with SLE exhibit aberrant PBX1 expression, which in turn drives disease progression by affecting their survival and differentiation and contributing to inflammatory amplification. The gene discussed is PBX1; the disease is systemic lupus erythematosus.